I find an investment in this company intriguing, because not only am I investing in cutting edge technology whose time has come, but I am also investing in potentially ending the suffering of countless human beings.
Here's to saving some lives...& EXTI Profits!
-Bill ^$^
From the Exten Homepage:
Hope for today's liver patients....
Growth Stock for Today's Investors
Sybiol?: Synthetic Bio-Artificial Liver technology...
Imagine a device that can do for liver failure what renal dialysis does for kidney failure, a device that would remove toxins from the blood. For years researchers worldwide have searched for a way to replicate the functions of the body's most complex organ, the liver.
Exten Industries, Inc., has created such a device. Known as the SYBIOL? synthetic bio-liver, the device operates outside the body, doing for the liver what dialysis machines do for people with kidney disease--and more.
"As the indications for liver transplantation have increased and as donor organs have become scarcer, the need for an artificial liver has become more imperative."
John J. Brems, M.D., F.A.C.S. Director of Transplantation at Loyola
University Medical Center
exten.com |
